Twist Bioscience (TWST) Finished Goods (2018 - 2026)

Twist Bioscience (TWST) has reported Finished Goods for 9 consecutive years, with $5.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Finished Goods fell 17.11% year-over-year to $5.4 million in Q2 2026; TTM through Jun 2026 was $5.4 million, a 17.11% decrease from a year earlier, with the FY2025 full-year figure at $5.9 million, up 26.8% from the prior year.
• Finished Goods was $5.4 million for Q2 2026 at Twist Bioscience, up from $5.0 million in the prior quarter.
• Over five years, Finished Goods peaked at $9.6 million in Q1 2022 and troughed at $3.9 million in Q3 2023.
• A 5-year average of $5.8 million and a median of $5.3 million in 2023 frame the typical range for Finished Goods.
• Across the five-year window, Finished Goods soared 415.24% in 2022 and plunged 48.71% in 2023, its largest moves.
• Over 5 years, Finished Goods stood at $7.4 million in 2022, then sank by 36.47% to $4.7 million in 2023, then rose by 2.75% to $4.8 million in 2024, then increased by 22.43% to $5.9 million in 2025, then decreased by 9.53% to $5.4 million in 2026.
• The last three Finished Goods figures came in at $5.4 million (Q2 2026), $5.0 million (Q1 2026), and $5.9 million (Q4 2025), per Business Quant data.